F Portaels

Author PubWeight™ 220.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995 15.19
2 Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995 6.95
3 Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994 5.64
4 Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 1993 5.52
5 A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997 5.28
6 Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol 1998 4.83
7 Insects in the transmission of Mycobacterium ulcerans infection. Lancet 1999 4.46
8 Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995 3.83
9 Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol 1992 3.65
10 Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997 3.55
11 Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis. J Clin Microbiol 1993 3.38
12 Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995 3.09
13 Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 1999 3.08
14 DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet 1989 2.91
15 Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000 2.71
16 IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol 1991 2.64
17 A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J Clin Microbiol 2000 2.43
18 Geographically distinct isolates of Mycobacterium leprae exhibit no genotypic diversity by restriction fragment-length polymorphism analysis. Mol Microbiol 1990 2.25
19 Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004 2.20
20 Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol 1992 2.18
21 Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh. Int J Tuberc Lung Dis 2004 2.08
22 Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 2000 2.01
23 Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 1995 1.94
24 Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol 2001 1.85
25 Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol 2001 1.85
26 Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998 1.85
27 Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol 1999 1.82
28 Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001 1.75
29 [Epidemiology of ulcers due to Mycobacterium ulcerans]. Ann Soc Belg Med Trop 1989 1.74
30 Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999 1.69
31 Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J Clin Microbiol 2002 1.67
32 Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol 1996 1.67
33 Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1999 1.63
34 [Buruli ulcer: risk of bone involvement! Apropos of 33 cases observed in Benin]. Med Trop (Mars) 2000 1.63
35 Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis 2007 1.62
36 Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis 1999 1.59
37 The use of IS2404 restriction fragment length polymorphisms suggests the diversity of Mycobacterium ulcerans from different geographical areas. Am J Trop Med Hyg 2001 1.54
38 Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases. Int J Tuberc Lung Dis 2001 1.53
39 Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun 2001 1.50
40 In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. J Antimicrob Chemother 2000 1.50
41 Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum. J Clin Microbiol 2001 1.49
42 Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004 1.48
43 Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol 1994 1.47
44 [Mycobacterium ulcerans cutaneous infections: Buruli ulcers]. Med Trop (Mars) 1995 1.44
45 Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2005 1.43
46 Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother 2001 1.40
47 Studies on Mycobacterium chelonei. J Med Microbiol 1972 1.40
48 Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol 1988 1.40
49 Further studies on African strains of Mycobacterium tuberculosis: comparison with M. bovis and M. microti. Ann Soc Belges Med Trop Parasitol Mycol 1970 1.38
50 Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg 1996 1.38
51 Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis 1998 1.32
52 First molecular epidemiological study of tuberculosis in Benin. Int J Tuberc Lung Dis 2009 1.28
53 Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis 2007 1.27
54 Evaluation of amplified fragment length polymorphism analysis for inter- and intraspecific differentiation of Mycobacterium bovis, M. tuberculosis, and M. ulcerans. J Clin Microbiol 2000 1.26
55 Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis 2004 1.24
56 Bleach sedimentation method for increased sensitivity of sputum smear microscopy: does it work? Int J Tuberc Lung Dis 2000 1.20
57 First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 2000 1.19
58 Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso. Tuber Lung Dis 1996 1.19
59 Evaluation of a commercial line probe assay for identification of mycobacterium species from liquid and solid culture. Eur J Clin Microbiol Infect Dis 2002 1.15
60 Growth of mycobacteria in relation to the pH of the medium. Ann Microbiol (Paris) 1983 1.14
61 Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol 1983 1.14
62 [Traditional treatment for Buruli ulcer in Benin]. Med Trop (Mars) 2004 1.13
63 The local immune response in ulcerative lesions of Buruli disease. Clin Exp Immunol 2006 1.13
64 Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998 1.12
65 Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J Clin Microbiol 1995 1.09
66 Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int J Tuberc Lung Dis 2006 1.09
67 A cooperative taxonomic study of mycobacteria isolated from armadillos infected with Mycobacterium leprae. J Gen Microbiol 1986 1.09
68 Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS. Res Microbiol 1992 1.09
69 Identificaion and clinical significance of Mycobacteria. Zentralbl Bakteriol Orig A 1972 1.08
70 Cases of Mycobacterium borstelense and M. abscessus infection observed in Belgium. J Med Microbiol 1971 1.07
71 Drug resistant tuberculosis in prisons in Azerbaijan: case study. BMJ 1998 1.06
72 Mycobacterium ulcerans infection in a child from Angola: diagnosis by direct detection and culture. Trop Med Int Health 1998 1.06
73 High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Int J Tuberc Lung Dis 2008 1.05
74 Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey. J Antimicrob Chemother 2007 1.04
75 Skin granulomas due to Mycobacterium gordonae. Int J Dermatol 1987 1.02
76 Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity. J Clin Microbiol 2001 1.01
77 DNA fingerprints of Mycobacterium tuberculosis do not change during the development of resistance to various antituberculous drugs. Tuber Lung Dis 1994 1.01
78 Difficulties encountered in identification of M. avium-M. intracellulare, M. scrofulaceum, and related strains. Am Rev Respir Dis 1978 1.01
79 Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol 1998 0.99
80 Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods. Clin Microbiol Infect 2007 0.99
81 [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin]. Trop Med Int Health 2005 0.97
82 Survival of Mycobacterium ulcerans at 37 degrees C. Clin Microbiol Infect 2007 0.97
83 Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect Dis 1999 0.97
84 Molecular investigation of recurrent tuberculosis in patients from Rwanda. Int J Tuberc Lung Dis 2007 0.96
85 The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. Int J Tuberc Lung Dis 2012 0.96
86 Long-term follow-up of pulmonary disease caused by Mycobacterium avium in a previously healthy patient. Acta Clin Belg 1993 0.96
87 Production of monoclonal antibodies against Mycobacterium leprae and armadillo-derived mycobacteria. Ann Inst Pasteur Microbiol 1986 0.95
88 Unclassified mycobacterial strains susceptible to dapsone isolated from the environment in Central Africa. Int J Lepr Other Mycobact Dis 1980 0.95
89 Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form. Ann Diagn Pathol 2000 0.94
90 DNA isolation from chloroform/methanol-treated mycobacterial cells without lysozyme and proteinase K. Biotechniques 2001 0.94
91 No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction. Dig Dis Sci 1996 0.94
92 Isolation of fastidiously growing mycobacteria from armadillo livers infected with Mycobacterium leprae. Int J Lepr Other Mycobact Dis 1982 0.93
93 Microaerophilic conditions promote growth of Mycobacterium genavense. J Clin Microbiol 1998 0.92
94 Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures. J Clin Microbiol 1997 0.91
95 Identification of a new variable number tandem repeat locus in Mycobacterium ulcerans for potential strain discrimination among African isolates. Clin Microbiol Infect 2007 0.91
96 Molecular epidemiology of drug-resistant Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Poland: a 1-year study. Int J Tuberc Lung Dis 2004 0.91
97 What is the meaning of repeated isolation of Mycobacterium africanum? Int J Tuberc Lung Dis 2000 0.91
98 Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required? Bull World Health Organ 2000 0.91
99 Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Int J Infect Dis 2007 0.90
100 [AIDS and atypical mycobacteria]. Ann Soc Belg Med Trop 1987 0.90
101 Isolation of mycobacteria from stools and intestinal biopsies from HIV seropositive and HIV seronegative patients with and without diarrhea in Kinshasa, Zaïre. Preliminary results. Ann Soc Belg Med Trop 1990 0.89
102 Traditional treatment of Buruli ulcer in Bénin. Arch Dermatol 1995 0.88
103 Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans. Infect Immun 2000 0.88
104 Specific identification of Mycobacterium leprae by the polymerase chain reaction. Mol Cell Probes 1990 0.88
105 Structural elucidation and antigenicity of a novel phenolic glycolipid antigen from Mycobacterium haemophilum. Biochemistry 1991 0.88
106 Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar. Int J Tuberc Lung Dis 2007 0.88
107 Restriction fragment length polymorphism (RFLP) analysis and tuberculosis epidemiology. Bull Pan Am Health Organ 1995 0.87
108 [Environmental mycobacteria in Lower Zaire]. Ann Soc Belg Med Trop 1973 0.87
109 [Follow-up of the first case of Mycobacterium ulcerans infection documented by PCR, genotyping and culture in the Republic of Congo-Brazzaville]. Med Trop (Mars) 2008 0.86
110 Systematic study of the 3-hydroxy fatty acid composition of mycobacteria. J Bacteriol 1994 0.85
111 Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases. Int J Infect Dis 2007 0.84
112 Growth and cytotoxic activity by Mycobacterium ulcerans in protein-free media. FEMS Microbiol Lett 1999 0.84
113 In vitro cultivation and characterization of Mycobacterium lepraemurium. Int J Lepr Other Mycobact Dis 1980 0.84
114 Drug resistant tuberculosis in sub-Saharan Africa: an estimation of incidence and cost for the year 2000. Tuber Lung Dis 1995 0.84
115 Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1997 0.84
116 DNA fingerprint analysis of drug resistant Mycobacterium tuberculosis strains isolated in the Czech Republic. Cent Eur J Public Health 1994 0.84
117 Parameters influencing the in vitro growth of Mycobacterium lepraemurium. Int J Lepr Other Mycobact Dis 1981 0.83
118 Acid-fast bacilli in Crohn's disease. Lancet 1988 0.82
119 Restriction fragment length polymorphism analysis of drug resistant Mycobacterium tuberculosis strains isolated in Belgium. Acta Clin Belg 1994 0.82
120 Use of gas chromatography to differentiate Mycobacterium leprae from cultivable armadillo-derived mycobacteria, M. avium/intracellulare, and M. lepraemurium by analysis of secondary alcohols. Int J Lepr Other Mycobact Dis 1985 0.82
121 [Study of names and folklore associated with Mycobacterium ulcerans infection in various endemic countries in Africa]. Med Trop (Mars) 2007 0.82
122 Mycobacteria isolated from the aquaria of the Antwerp Zoo. Acta Zool Pathol Antverp 1971 0.82
123 Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 2005 0.82
124 Use of DNA restriction fragment typing in the differentiation of Mycobacterium tuberculosis complex isolates from animals and humans in Burundi. Tuber Lung Dis 1996 0.82
125 Two-dimensional gas chromatography with electron capture detection for the sensitive determination of specific mycobacterial lipid constituents. J Clin Microbiol 1989 0.82
126 Characterization of Mycobacterium avium complex related mycobacteria isolated from an African environment and patients with AIDS. Trop Med Int Health 1997 0.81
127 Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas. Clin Exp Immunol 2009 0.81
128 Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Int J Tuberc Lung Dis 1999 0.81
129 Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA). Int J Tuberc Lung Dis 1997 0.80
130 [Buruli ulcer in 2004]. Med Trop (Mars) 2004 0.80
131 Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis. Int J Tuberc Lung Dis 2006 0.79
132 Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2009 0.79
133 The importance and evaluation of mycobacterial diseases as assessed by a mycobacteriological laboratory. Bull Int Union Tuberc Lung Dis 1988 0.79
134 Cultivable mycobacteria isolated from organs of armadillos uninoculated and inoculated with Mycobacterium leprae. Ann Inst Pasteur Microbiol 1985 0.79
135 Study of unclassified dapsone sensitive mycobacteria isolated from the environment in Zaire. Ann Soc Belg Med Trop 1980 0.79
136 Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates. Microb Drug Resist 2000 0.78
137 Rapid, early and specific diagnosis of tuberculosis and other mycobacterial diseases in Burundi. Ann Soc Belg Med Trop 1993 0.78
138 Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopenia. Tuber Lung Dis 1996 0.78
139 Correlation viability/morphology in Mycobacterium leprae. Acta Leprol 1985 0.77
140 [Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC)]. Bull Soc Pathol Exot 2007 0.77
141 [Primary and acquired resistance to antituberculous drugs in strains of Mycobacterium tuberculosis isolated in Rwanda]. Med Trop (Mars) 2007 0.77
142 New data on the ultrastructure of the membrane of Mycobacterium leprae. Int J Lepr Other Mycobact Dis 1989 0.77
143 Bacteriological studies of armadillo livers infected with Mycobacterium leprae. Ann Soc Belg Med Trop 1982 0.76
144 Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. Antimicrob Agents Chemother 2000 0.75
145 Microcolony detection for rapid diagnosis of Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 2000 0.75
146 In vitro sensitivity of Mycobacterium lepraemurium for antimycobacterial drugs. Arzneimittelforschung 1982 0.75
147 [Lipid composition of cultivable Mycobacteria isolated from livers of armadillos infected by Mycobacterium leprae]. Ann Microbiol (Paris) 1984 0.75
148 [A case of pulmonary mycobacteriosis due to Mycobacterium intracellulare (author's transl)]. Pathol Biol (Paris) 1982 0.75
149 Social research as an intervention tool in tuberculosis control. Int J Tuberc Lung Dis 2004 0.75
150 [The leprosy bacillus: expectations for culturing and vaccination]. Bull Mem Acad R Med Belg 1987 0.75
151 Mycobacterium simiae disseminated infection in a patient with acquired immunodeficiency syndrome. Infection 1996 0.75
152 Nocardia-like mycobacteria isolated from natural habitats in Zaire. Ann Soc Belg Med Trop 1981 0.75
153 Cutaneous ulcer caused by Mycobacterium avium and recurrent genital herpes after highly active antiretroviral therapy. Arch Dermatol 2000 0.75
154 [Wounds of the hand and forearm due to stab phenomenon Kuluna in Kinshasa (Democratic Republic of Congo): Types of injuries and treatment]. Rev Med Brux 2016 0.75
155 Fast atom bombardment mass spectrometry of mycobacterial phenolic glycolipids. Biol Mass Spectrom 1994 0.75
156 Branched Mycobacterium-like organisms from swine lymph nodes. Vet Microbiol 1982 0.75
157 Immunodiffusion analyses of environmental mycobacteria isolated in Zaire. Zentralbl Bakteriol Mikrobiol Hyg A 1985 0.75
158 About two cases of Mycobacterium simiae infection in AIDS: review of the pathogenicity. Acta Clin Belg 1998 0.75
159 [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis]. Bol Oficina Sanit Panam 1995 0.75
160 [Isolation and distribution of Nocardiae in the Bas-Zaire]. Ann Soc Belg Med Trop 1976 0.75
161 Taxonomy of Mycobacterium leprae and M. lepraemurium. Ann Microbiol (Paris) 1982 0.75
162 Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria. Arzneimittelforschung 1981 0.75
163 Bulk staining of smears: no demonstrated risk of bacilli transfer from a positive to a negative smear. Int J Tuberc Lung Dis 2008 0.75
164 Sensitivity of mycobacteria to dapsone. Arzneimittelforschung 1982 0.75
165 Resistance to ethambutol as an aid to the identification of Mycobacterium friedmannii (abscessus) and M. borstelense. J Med Microbiol 1970 0.75
166 [Tuberculosis: multidrug-resistance in Belgium in 1992 and 1993]. Acta Clin Belg 1996 0.75
167 [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis]. Pneumologie 1995 0.75
168 Multi drug resistant tuberculosis: what will happen in developing countries? Ann Soc Belg Med Trop 1994 0.75